您当前的位置:
首页 >
文章列表页 >
GLP-1(7-36) inhibits atherosclerosis progression in ApoE-/- mouse aorta by lowering expressions of CD36 and ACAT1 in foam cells
更新时间:2021-08-02
    • GLP-1(7-36) inhibits atherosclerosis progression in ApoE-/- mouse aorta by lowering expressions of CD36 and ACAT1 in foam cells

    • Journal of Army Medical University   Vol. 41, Issue 20, Pages: 1947-1953(2019)
    • 作者机构:

      山西医科大学第二医院心血管内科

    • DOI:10.16016/j.1000-5404.201905050    

      CLC: R-332;R543.1
    • Published:2019,

    扫 描 看 全 文

  • HAN Yongkui, YUE Yunfei, ZHANG Kui, et al. GLP-1(7-36) inhibits atherosclerosis progression in ApoE-/- mouse aorta by lowering expressions of CD36 and ACAT1 in foam cells. [J]. Journal of Army Medical University 41(20):1947-1953(2019) DOI: 10.16016/j.1000-5404.201905050.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Dihydromyricetin ameliorates vascular endothelial damage by inhibiting NLRP3 inflammasome activity through Sirtuin 3
Melatonin inhibits ox-LDL-induced proliferation   of vascular smooth muscle cells
Effects of platelet microparticles on atherosclerotic plaque formation and stability in ApoE-/- mice
Sulforaphane inhibits hepatic steatosis in rats by down-regulating DGAT2 and ACAT1 expression
CD36 knockdown alleviates lipid accumulation induced by tumor necrosis factor-α and interleukin-6 in HepG2 cells

Related Author

ZHANG Ting
ZHOU Xi
WANG Xiaolan
SHEN Hui
LIU Minghua
LIU Chuan
TANG Yang
KANG Huali

Related Institution

Department of Nutrition and Food Hygiene, Chongqing Key Laboratory of Nutrition and Food Safety, Chongqing Medical Nutrition Research Center, Faculty of Military Preventive Medicine, Army Medical University (Third Military Medical University)
Department of Cardiovascular Diseases, Second Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Cardiology, General Hospital of Central Theater
Third Military Medical University
Center of Drug Safety and Evaluation, Heilongjiang University of Chinese Medicine
0